One-carbon metabolism is altered in Sengers syndrome patient cells [43,45], owing to the perturbed biogenesis of the novel TIMM22 complex substrates, SFXN1, SFXN2 and SFXN3 [40,46]. Here, TIMM22 is linked to Sengers syndrome.